Page 34 - GTM-3-3

Global Translational Medicine Computational advances in cancer liquid biopsy

14. Van Wezel EM, Zwijnenburg D, Zappeij-Kannegieter L, 25. Franken B, De Groot MR, Mastboom WJ, et al. Circulating
et al. Whole-genome sequencing identifies patient-specific tumor cells, disease recurrence and survival in newly
DNA minimal residual disease markers in neuroblastoma. diagnosed breast cancer. Breast Cancer Res. 2012;14(5):R133.
J Mol Diagn. 2015;17(1):43-52. doi: 10.1186/bcr3333
doi: 10.1016/j.jmoldx.2014.09.005 26. Poruk KE, Valero V, He J, et al. Circulating epithelial cells
15. Wang Y, Li L, Cohen JD, et al. Prognostic potential of in intraductal papillary mucinous neoplasms and cystic
circulating tumor DNA measurement in postoperative pancreatic lesions. Pancreas. 2017;46(7):943-947.
surveillance of nonmetastatic colorectal cancer. JAMA doi: 10.1097/MPA.0000000000000869
Oncol. 2019;5(8):1118-1123.
27. Franses JW, Basar O, Kadayifci A, et al. Improved detection of
doi: 10.1001/jamaoncol.2019.0512 circulating epithelial cells in patients with intraductal papillary
16. Newman AM, Bratman SV, To J, et al. An ultrasensitive mucinous neoplasms. Oncologist. 2018;23(1):121-127.
method for quantitating circulating tumor DNA with broad doi: 10.1634/theoncologist.2017-0234
patient coverage. Nat Med. 2014;20(5):548-554.
28. Man Y, Wang Q, Kemmner W. Currently used markers
doi: 10.1038/nm.3519 for CTC isolation - advantages, limitations and impact on
cancer prognosis. J Clin Exp Pathol. 2011;1(1):102.
17. Phallen J, Sausen M, Adleff V, et al. Direct detection of early-
stage cancers using circulating tumor DNA. Sci Transl Med. doi: 10.4172/2161-0681.1000102
2017;9(403):eaan2415.
29. Alix-Panabières C, Pantel K. Liquid biopsy: From discovery
doi: 10.1126/scitranslmed.aan2415 to clinical application. Cancer Discov. 2021;11(4):858-873.
18. Abbosh C, Birkbak NJ, Wilson GA, et al. Phylogenetic doi: 10.1158/2159-8290.CD-20-1311
ctDNA analysis depicts early-stage lung cancer evolution. 30. Ni X, Zhuo M, Su Z, et al. Reproducible copy number variation
Nature. 2017;545(7655):446-451. patterns among single circulating tumor cells of lung cancer
doi: 10.1038/nature22364 patients. Proc Natl Acad Sci. 2013;110(52):21083-21088.
19. Adalsteinsson VA, Ha G, Freeman SS, et al. Scalable whole- doi: 10.1073/pnas.1320659110
exome sequencing of cell-free DNA reveals high concordance 31. Court CM, Hou S, Liu L, et al. Somatic copy number
with metastatic tumors. Nat Commun. 2017;8(1):1324. profiling from hepatocellular carcinoma circulating tumor
doi: 10.1038/s41467-017-00965-y cells. NPJ Precis Oncol. 2020;4(1):16.
20. Zviran A, Schulman RC, Shah M, et al. Genome-wide cell- doi: 10.1038/s41698-020-0123-0
free DNA mutational integration enables ultra-sensitive 32. Silvestri M, Dugo M, Vismara M, et al. Copy number
cancer monitoring. Nat Med. 2020;26(7):1114-1124. alterations analysis of primary tumor tissue and circulating
tumor cells from patients with early-stage triple negative
doi: 10.1038/s41591-020-0915-3
breast cancer. Sci Rep. 2022;12(1):1470.
21. Snyder MW, Kircher M, Hill AJ, Daza RM, Shendure J. Cell-
free DNA comprises an in vivo nucleosome footprint that doi: 10.1038/s41598-022-05502-6
informs its tissues-of-origin. Cell. 2016;164(1-2):57-68. 33. Baslan T, Kendall J, Rodgers L, et al. Genome-wide copy number
analysis of single cells. Nat Protoc. 2012;7(6):1024-1041.
doi: 10.1016/j.cell.2015.11.050
doi: 10.1038/nprot.2012.039
22. Mouliere F, Chandrananda D, Piskorz AM, et al. Enhanced
detection of circulating tumor DNA by fragment size 34. Ross MG, Russ C, Costello M, et al. Characterizing and
analysis. Sci Transl Med. 2018;10(466):eaat4921. measuring bias in sequence data. Genome Biol. 2013;14(5):R51.
doi: 10.1126/scitranslmed.aat4921 doi: 10.1186/gb-2013-14-5-r51
23. Widman AJ, Shah M, Frydendahl A, et al. Ultrasensitive 35. Lasken RS, Stockwell TB. Mechanism of chimera formation
plasma-based monitoring of tumor burden using during the Multiple Displacement Amplification reaction.
machine-learning-guided signal enrichment. Nat Med. BMC Biotechnol. 2007;7(1):19.
2024;30(6):1655-1666. doi: 10.1186/1472-6750-7-19
doi: 10.1038/s41591-024-03040-4 36. Salter SJ, Cox MJ, Turek EM, et al. Reagent and laboratory
24. Kidess E, Jeffrey SS. Circulating tumor cells versus tumor- contamination can critically impact sequence-based
derived cell-free DNA: Rivals or partners in cancer care in microbiome analyses. BMC Biol. 2014;12(1):87.
the era of single-cell analysis? Genome Med. 2013;5(8):70. doi: 10.1186/s12915-014-0087-z
doi: 10.1186/gm474 37. Merchant S, Wood DE, Salzberg SL. Unexpected cross-

Volume 3 Issue 3 (2024) 11 doi: 10.36922/gtm.3063